Research graph
References from Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1101/cshperspect.a003236
10.1101/cshperspect.a003236 · External reference
10.1016/j.molonc.2007.01.004
10.1016/j.molonc.2007.01.004 · External reference
10.1016/s0092-8674(00)81683-9
10.1016/s0092-8674(00)81683-9 · External reference
10.1016/j.ajpath.2016.02.023
10.1016/j.ajpath.2016.02.023 · External reference
10.1038/nrg.2016.59
10.1038/nrg.2016.59 · External reference
10.15252/emmm.201303698
10.15252/emmm.201303698 · External reference
10.1016/j.devcel.2018.02.015
10.1016/j.devcel.2018.02.015 · External reference
10.1038/nrc1370
10.1038/nrc1370 · External reference
10.1016/j.cell.2017.01.018
10.1016/j.cell.2017.01.018 · External reference
10.1007/s10555-016-9611-7
10.1007/s10555-016-9611-7 · External reference
Tumor-educated platelets as liquid biopsy in cancer patients
10.1016/j.ccell.2015.10.007 · 2015 · External reference
Biology and clinical significance of circulating tumor cell subpopulations in lung cancer
10.21037/tlcr.2017.07.03 · 2017 · External reference
Changes in keratin expression during metastatic progression of breast cancer: impact on the detection of circulating tumor cells
10.1158/1078-0432.ccr-11-2100 · 2012 · External reference
Circulating tumor cells in patients with breast cancer dormancy
10.1158/1078-0432.ccr-04-1110 · 2004 · External reference
Dynamic changes in numbers and properties of circulating tumor cells and their potential applications
10.3390/cancers6042369 · 2014 · External reference
10.1016/j.ccell.2015.09.018
10.1016/j.ccell.2015.09.018 · External reference
10.1038/ncb3015
10.1038/ncb3015 · External reference
10.1007/s10555-017-9674-0
10.1007/s10555-017-9674-0 · External reference
The potential of liquid biopsies for the early detection of cancer
10.1038/s41698-017-0039-5 · 2017 · External reference
10.1016/j.ccr.2014.03.007
10.1016/j.ccr.2014.03.007 · External reference
10.1016/j.ccell.2017.01.002
10.1016/j.ccell.2017.01.002 · External reference
Cell-free fetal DNA-based noninvasive prenatal testing of aneuploidy
10.1111/tog.12388 · 2017 · External reference
10.1038/nrc.2017.7
10.1038/nrc.2017.7 · External reference
10.1002/ijc.28030
10.1002/ijc.28030 · External reference
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
10.1073/pnas.1500076112 · 2015 · External reference
10.1038/pcan.2017.7
10.1038/pcan.2017.7 · External reference
Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer
10.1196/annals.1448.025 · 2008 · External reference
10.1371/journal.pone.0140712
10.1371/journal.pone.0140712 · External reference
10.1158/0008-5472.can-09-3513
10.1158/0008-5472.can-09-3513 · External reference
Cancer progression mediated by horizontal gene transfer in an in vivo model
10.1371/journal.pone.0052754 · 2012 · External reference
10.18632/oncotarget.17858
10.18632/oncotarget.17858 · External reference
10.1146/annurev-med-062310-094219
10.1146/annurev-med-062310-094219 · External reference
DNA methylation analysis: choosing the right method
2016 · External reference
10.1016/j.ebiom.2016.06.032
10.1016/j.ebiom.2016.06.032 · External reference
10.1038/nm.1789
10.1038/nm.1789 · External reference
Cell-free DNA in non-small cell lung cancer
10.6001/actamedica.v24i2.3495 · 2017 · External reference
The Emerging role of “liquid biopsies,” circulating tumor cells, and circulating cell-free tumor DNA in lung cancer diagnosis and identification of resistance mutations
10.1007/s11912-017-0564-y · 2017 · External reference
Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testing
10.21037/tlcr.2016.12.03 · 2016 · External reference
10.1016/j.jmoldx.2016.09.009
10.1016/j.jmoldx.2016.09.009 · External reference
Quantity versus quality: optimal methods for cell-free DNA isolation from plasma of pregnant women
10.1097/01.gim.0000241904.32039.6f · 2006 · External reference
Poly(A) extensions of miRNAs for amplification-free electrochemical detection on screen-printed gold electrodes
10.1021/acs.analchem.5b04795 · 2016 · External reference
Comparison of 7 methods for extracting cell-free DNA from serum samples of colorectal cancer patients
10.1373/clinchem.2008.110122 · 2009 · External reference
An improved method for the isolation of free-circulating plasma DNA and cell-free DNA from other body fluids
10.1196/annals.1448.035 · 2008 · External reference
The most favourable procedure for the isolation of cell-free DNA from the plasma of iso-immunized RHD-negative pregnant women
10.5772/62113 · 2015 · External reference
Cell-free DNA: measurement in various carcinomas and establishment of normal reference range
10.1016/s0009-8981(02)00091-8 · 2002 · External reference
Improved method for isolating cell-free DNA
10.1373/clinchem.2005.051003 · 2005 · External reference
Identification of loss of heterozygosity on circulating free DNA in peripheral blood of prostate cancer patients: potential and technical improvements
10.1373/clinchem.2007.099333 · 2008 · External reference
10.18632/oncotarget.21134
10.18632/oncotarget.21134 · External reference
10.1371/journal.pmed.1002205
10.1371/journal.pmed.1002205 · External reference
Quantification of free circulating DNA as a diagnostic marker in lung cancer
10.1200/jco.2003.02.006 · 2003 · External reference
Circulating DNA: diagnostic tool and predictive marker for overall survival of NSCLC patients
10.1371/journal.pone.0038559 · 2012 · External reference
10.15252/emmm.201404913
10.15252/emmm.201404913 · External reference
Quantitative analysis of cell-free DNA in ovarian cancer
10.3892/ol.2015.3771 · 2015 · External reference
Comparison of circulating plasma DNA levels between lung cancer patients and healthy controls
10.2353/jmoldx.2009.080098 · 2009 · External reference
Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients
2001 · External reference
Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection
10.4174/astr.2014.86.3.136 · 2014 · External reference
Measurement of circulating cell-free DNA levels by a new simple fluorescent test in patients with primary colorectal cancer
10.1309/ajcp4rk2ihvkttzv · 2011 · External reference
Quantitative analysis of circulating plasma DNA as a tumor marker in thoracic malignancies
10.1373/clinchem.2004.039263 · 2005 · External reference
10.1007/s10549-015-3322-6
10.1007/s10549-015-3322-6 · External reference
10.1016/j.cca.2014.03.024
10.1016/j.cca.2014.03.024 · External reference
10.1126/scitranslmed.3007094
10.1126/scitranslmed.3007094 · External reference
A modified extraction method of circulating free DNA for epidermal growth factor receptor mutation analysis
10.3349/ymj.2012.53.1.132 · 2012 · External reference
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
10.1126/scitranslmed.aab0021 · 2015 · External reference
Noninvasive detection of activating estrogen receptor 1 (ESR1) mutations in estrogen receptor-positive metastatic breast cancer
10.1373/clinchem.2015.238717 · 2015 · External reference
10.1038/nm.3854
10.1038/nm.3854 · External reference
10.1200/jco.2016.67.3061
10.1200/jco.2016.67.3061 · External reference
Detection of KIT and PDGFRA mutations in the plasma of patients with gastrointestinal stromal tumor
10.1007/s11523-015-0361-1 · 2015 · External reference
10.1158/2159-8290.cd-17-0343
10.1158/2159-8290.cd-17-0343 · External reference
Concentration and methylation of cell-free DNA from blood plasma as diagnostic markers of renal cancer
10.1155/2016/3693096 · 2016 · External reference
The acquisition of Hmlh1methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients
10.1158/1078-0432.ccr-03-0732 · 2004 · External reference
10.1158/1078-0432.ccr-17-1181
10.1158/1078-0432.ccr-17-1181 · External reference
10.1016/j.biomaterials.2016.06.003
10.1016/j.biomaterials.2016.06.003 · External reference
Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA
10.1126/scitranslmed.3003726 · 2012 · External reference
10.1038/nprot.2014.170
10.1038/nprot.2014.170 · External reference
Circulating tumor cells revisited
10.1001/jama.2010.292 · 2010 · External reference
10.1016/j.jmoldx.2012.08.007
10.1016/j.jmoldx.2012.08.007 · External reference
Circulating tumor DNA outperforms circulating tumor cells for KRAS mutation detection in thoracic malignancies
10.1373/clinchem.2015.242453 · 2015 · External reference
10.1158/1078-0432.ccr-13-2933
10.1158/1078-0432.ccr-13-2933 · External reference
10.1111/j.1755-0998.2011.03024.x
10.1111/j.1755-0998.2011.03024.x · External reference
10.1016/j.cell.2015.11.050
10.1016/j.cell.2015.11.050 · External reference
10.1158/1078-0432.ccr-15-1627-t
10.1158/1078-0432.ccr-15-1627-t · External reference
10.1158/0008-5472.can-11-4037
10.1158/0008-5472.can-11-4037 · External reference
10.1158/1078-0432.ccr-13-3063
10.1158/1078-0432.ccr-13-3063 · External reference
Diagnostic accuracy of noninvasive genotyping of EGFR in lung cancer patients by deep sequencing of plasma cell-free DNA
10.1373/clinchem.2015.241414 · 2015 · External reference
10.1038/nature22364
10.1038/nature22364 · External reference
mFast-SeqS as a monitoring and pre-screening tool for tumor-specific aneuploidy in plasma DNA
10.1007/978-3-319-42044-8_28 · 2016 · External reference
10.1373/clinchem.2014.234286
10.1373/clinchem.2014.234286 · External reference
10.1371/journal.pone.0041162
10.1371/journal.pone.0041162 · External reference
10.1371/journal.pone.0194630
10.1371/journal.pone.0194630 · External reference
10.1073/pnas.1105422108
10.1073/pnas.1105422108 · External reference
10.1093/annonc/mdv177
10.1093/annonc/mdv177 · External reference
Unresolved reference
2016 · External reference
10.1038/nm.3519
10.1038/nm.3519 · External reference
10.1038/ncomms11815
10.1038/ncomms11815 · External reference
10.1038/nbt.3520
10.1038/nbt.3520 · External reference
Standards and guidelines for validating next-generation sequencing bioinformatics pipelines
10.1016/j.jmoldx.2017.11.003 · 2018 · External reference
Translational bioinformatics for diagnostic and prognostic prediction of prostate cancer in the next-generation sequencing era
2013 · External reference
Cancer bioinformatics: a new approach to systems clinical medicine
10.1186/1471-2105-13-71 · 2012 · External reference
10.1093/bioinformatics/btp324
10.1093/bioinformatics/btp324 · External reference
10.1186/gb-2009-10-3-r25
10.1186/gb-2009-10-3-r25 · External reference
10.1093/bioinformatics/bts635
10.1093/bioinformatics/bts635 · External reference
Review of current methods, applications, and data management for the bioinformatics analysis of whole exome sequencing
10.4137/cin.s13779 · 2014 · External reference
10.1101/gr.107524.110
10.1101/gr.107524.110 · External reference
10.1038/nmeth.1363
10.1038/nmeth.1363 · External reference
10.1186/1471-2105-13-8
10.1186/1471-2105-13-8 · External reference
Unresolved reference
2012 · External reference
10.1093/bioinformatics/btw536
10.1093/bioinformatics/btw536 · External reference
PCR-based methods for detecting single-locus DNA methylation biomarkers in cancer diagnostics, prognostics, and response to treatment
10.1373/clinchem.2008.121962 · 2009 · External reference
10.1158/2159-8290.cd-15-1283
10.1158/2159-8290.cd-15-1283 · External reference
10.1016/j.dld.2015.05.023
10.1016/j.dld.2015.05.023 · External reference
10.1373/clinchem.2013.206359
10.1373/clinchem.2013.206359 · External reference
10.1200/jco.2016.66.7162
10.1200/jco.2016.66.7162 · External reference
10.1038/nmeth850
10.1038/nmeth850 · External reference
Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood
10.1158/1078-0432.ccr-11-2696 · 2012 · External reference
10.1158/1078-0432.ccr-11-1712
10.1158/1078-0432.ccr-11-1712 · External reference
10.1016/j.lungcan.2015.10.004
10.1016/j.lungcan.2015.10.004 · External reference
High sensitivity detection of tumor gene mutations
10.24947/baojcrt/00101 · 2015 · External reference
Predicting the sensitivity and specificity of published real-time PCR assays
10.1186/1476-0711-7-18 · 2008 · External reference
10.1038/nm.3511
10.1038/nm.3511 · External reference
Amplification-refractory mutation system (ARMS) analysis of point mutations
2001 · External reference
Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer
2018 · External reference
10.1111/j.1349-7006.2007.00706.x
10.1111/j.1349-7006.2007.00706.x · External reference
Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping
10.1186/1756-9966-32-50 · 2013 · External reference
EGFR mutation analysis of circulating tumor DNA using an improved PNA-LNA PCR clamp method
2016 · External reference
Simple, sensitive and accurate multiplex detection of clinically important melanoma DNA mutations in circulating tumour DNA with SERS nanotags
10.7150/thno.15871 · 2016 · External reference
Ultrasensitive detection of multiplexed somatic mutations using MALDI-TOF mass spectrometry
10.1016/j.jmoldx.2015.08.001 · 2016 · External reference
10.1038/bjc.2015.80
10.1038/bjc.2015.80 · External reference
10.1039/c2cp43859c
10.1039/c2cp43859c · External reference
10.1016/j.clinbiochem.2017.02.017
10.1016/j.clinbiochem.2017.02.017 · External reference
10.1038/cr.2015.126
10.1038/cr.2015.126 · External reference
Unresolved reference
2017 · External reference
Unresolved reference
2017 · External reference
The Cobas® EGFR Mutation Test v2 assay
10.2217/fon.15.311 · 2016 · External reference
10.1373/clinchem.2013.203679
10.1373/clinchem.2013.203679 · External reference
Exercise is a potent stimulus for enhancing circulating DNase activity
10.1016/j.clinbiochem.2013.12.017 · 2014 · External reference
The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells
10.1111/j.1365-2567.2005.02130.x · 2005 · External reference
